Stabilization of a Broadly Neutralizing Anti-Chikungunya Virus Single Domain Antibody

Abstract

A single domain antibody (clone CC3) previously found to neutralize a vaccine strain of the chikungunya virus (PRNT50 = 2. 5 ng/mL) was found to be broadly neutralizing. Clone CC3 is not only able to neutralize a wild-type (WT) strain of chikungunya virus (CHIKV), but also neutralizes WT strains of Mayaro virus (MAYV) and Ross River virus (RRV); both arthralgic, Old World alphaviruses. Interestingly, CC3 also demonstrated a degree of neutralizing activity against the New World alphavirus, Venezuelan equine encephalitis virus (VEEV); albeit both the vaccine strain, TC-83, and the parental, WT Trinidad donkey strain had PRNT50 values ~1,000-fold higher than that of CHIKV. However, no neutralization activity was observed with Western equine encephalitis virus (WEEV). Ten CC3 variants designed to possess a range of isoelectric points, both higher and lower, were constructed. This approach successfully identified several lower pI mutants which possessed improved thermal stabilities by as much as 10°C over the original CC3 (Tm = 62°C), and excellent refolding abilities while maintaining their capacity to bind and neutralize CHIKV.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 28, 2021
Source ID
10.3389/fmed.2021.626028

Entities

People

  • Christina L Gardner
  • Crystal W Burke
  • Dan Zabetakis
  • Ellen R Goldman
  • Emily M. Webb
  • George P. Anderson
  • James Weger-Lucarelli
  • Jinny L. Liu
  • Pamela J Glass
  • Patricia M Legler

Organizations

  • Defense Threat Reduction Agency

Tags

Fields of Study

  • Biology

Readers

  • Molecular and Cellular Biochemistry
  • Virology (or Medical Virology).

Technology Areas

  • Biotechnology